Open AccessPlasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention
Author(s) -
Tse-Min Lu,
Yu-An Ding,
ShingJong Lin,
Wen-Shin Lee,
Ho-Charng Tai
Publication year - 2003
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1016/j.ehj.2003.08.013
Subject(s) - medicine , percutaneous coronary intervention , conventional pci , asymmetric dimethylarginine , cardiology , myocardial infarction , adverse effect , risk factor , unstable angina , arginine , biochemistry , chemistry , amino acid
We investigated the predictive value of plasma concentration of asymmetrical dimethylarginine (ADMA) on clinical outcome in patients undergoing percutaneous coronary intervention (PCI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom